Results 161 to 170 of about 7,337,590 (301)
Tada Kunavisarut, Sutin Sriussadaporn, Raweewan LertwattanarakDivision of Endocrinology and Metabolism, Siriraj Hospital, Mahidol University, Bangkok, ThailandBackground: The aim of this study was to investigate beta-cell function and examine whether ...
Sriussadaporn S +2 more
core
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Real parts of the special function B(x,y), the beta function, which was studied by Euler, Legendre, Binet, Whittaker, Watson, and othersComponente Curricular::Educação Superior::Ciências Exatas e da Terra ...
Carvalho, Daniel de Souza
core +1 more source
[STAMMBUCH BETA KHAMPF] [Stammbuch Beta Khampf] ( - ) Cover ( - ) Einträge Bl. 1 - 2 ( - ) Titelblatt, Bl. 3 ( - ) Einträge Bl. 4 - 10 ( - ) Einträge Bl. 11 - 20 ( - ) Einträge Bl. 21 - 30 ( - ) Einträge Bl. 31 -
Khampf, Beta
core
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Weighted Beta Regression for Modeling Bounded Data. [PDF]
Bourguignon M, Gallardo DI, Vila R.
europepmc +1 more source
Beta-cell function is associated with metabolic syndrome in Mexican subjects
Blanca G Baez-Duarte1,3, María Del Carmen Sánchez-Guillén3†, Ricardo Pérez-Fuentes2,3, Irma Zamora-Ginez1,3, Bertha Alicia Leon-Chavez1, Cristina Revilla-Monsalve4, Sergio Islas-Andrade41Posgrado en ...
Blanca G Baez-Duarte +3 more
core
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Evidence for Reductions in Fungal Richness and Beta Diversity Dispersion Associated With Impervious Surfaces in California. [PDF]
Simons AL +3 more
europepmc +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source

